Understanding preferences regarding the offer of elective induction of labor to inform development of a decision support tool
Understanding preferences regarding the offer of elective induction of labor to inform development of a decision support tool
批准号:
10730074
负责人:
MIRIAM KUPPERMANN
金额:
$9.03万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-06-05 至 2023-05-31
中文摘要
项目摘要/摘要-项目摘要/摘要不会因此而更改
制度的变更
剖腹产(CD)是美国最常见的住院手术,占近三分之一
每年的出生率。许多组织已将降低CD率作为一项重要的公共卫生目标
目标;然而,确定实现这一目标的干预措施是具有挑战性的。此外,确定
当分娩的好处超过持续怀孕的好处时,这是产科的核心困境之一
护理,并从母亲和新生儿的角度确定最佳分娩时间
一个争论不休的话题。39周分娩被认为是新生儿最理想的分娩方式,但它也
有人认为,引产的广泛使用是导致剖宫产率高的原因之一。
此外,在没有明确医学指征的情况下干预怀孕的适当性很高。
有争议的。
最近发表了一项关于39岁引产的随机试验--到达试验的研究结果
在6100多名未分娩的妇女中,为期数周的治疗与期待治疗相比,可能会影响这一计算
意义重大。在这项大型多中心研究中,39周时选择性引产与
剖宫产率下降,先兆子痫减少,新生儿呼吸需求减少
在不良围产期结局方面没有统计学上的显著差异。
考虑到很难找到降低剖宫产率和改善孕产妇状况的干预措施
结果,这些发现对产科实践的潜在影响是重要的。然而,虽然
与39周选择性引产相关的临床结果是令人信服的,还有许多未知之处。
关于患者和提供者将如何看待实践中的如此重大变化。在临床上的期待
鉴于新的数据,可能会建议在39周内提供引产的指导方针是
关键是我们要对这些利益相关者如何看待例行报价的前景有一个细致入微的了解
引产时间为39周。此外,鉴于这一讨论涉及的潜在复杂性以及
将面临这一决定的大量女性,这是一个改进决策工具的理想目标
提高效率,并优化将知情的患者偏好纳入这一决定。
拟议的研究寻求1)在孕妇和产前护理中进行形成性研究
提供者关于他们如何看待39周后选择性引产的提议,2)使用此
创建关于选任归纳的原型决策工具的信息,以及3)进行试点
对该工具的可行性和可接受性进行研究。我们的最终目标是对此进行随机试验
决策支持工具,用于评估其对引产率、剖宫产率、资源利用率、
决策质量,以及患者对分娩和分娩过程的满意度。
第1页
英文摘要
Project Summary/Abstract – There are no changes to the Project Summary/Abstract as a result of this
change of institution
Cesarean delivery (CD) is the most common inpatient surgery in the US, accounting for nearly one third
of births annually. Numerous organizations have targeted reducing the CD rate as an important public health
goal; however, identifying interventions to achieve this goal has proven challenging. In addition, determining
when the benefits of delivery outweigh those of ongoing pregnancy is one of the central dilemmas of obstetric
care, and defining the optimal timing of delivery from the perspective of the mother and the neonate has been
a topic of much debate. Delivery at 39 weeks has been proposed as optimal for the neonate, but it has also
been suggested that the widespread use of induction has contributed to the high rate of cesarean deliveries.
In addition, the appropriateness of intervening in pregnancy without a clear medical indication is highly
controversial.
The recent presentation of the findings of the ARRIVE trial, a randomized trial of induction of labor at 39
weeks versus expectant management in more than 6100 nulliparous women, is poised to impact this calculus
significantly. In this large multicenter study, elective induction of labor at 39 weeks was associated with a
decrease in cesarean rate, a decrease in preeclampsia and a decrease in need for neonatal respiratory
support without a statistically significant difference in adverse perinatal outcomes.
Given the difficulty in identifying interventions to decrease the cesarean rate and improve maternal
outcomes, the potential implications of these findings on obstetric practice are significant. However, while the
clinical outcomes associated with elective induction at 39 weeks are compelling, there is much that is unknown
about how patients and providers would view such a significant change in practice. In anticipation of clinical
guidelines that are likely to recommend the offer of induction of labor at 39 weeks in view of the new data, it is
critical that we gain a nuanced understanding of how these stakeholders view the prospect of a routine offer of
induction at 39 weeks. In addition, given the potential complexity involved in this discussion as well as the
significant population of women who will face this decision, it is an ideal target for a decision tool to improve
efficiency and optimize the incorporation of informed patient preferences in this decision.
The proposed study seeks 1) to conduct formative research among pregnant women and prenatal care
providers regarding how they would view the offer of elective induction of labor at 39 weeks, 2) to use this
information in the creation of a prototype decision tool regarding elective induction, and 3) to conduct a pilot
study of feasibility and acceptability of the tool. Our ultimate goal is to conduct a randomized trial of this
decision support tool to assess its impact on induction rates, cesarean delivery rates, resource utilization,
decision quality, and patient satisfaction with the labor and delivery process.
Page 1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Promoting Shared Decision Making in Periviable Care: A randomized controlled trial of the Periviable GOALS Decision Support Tool
-
批准号:10366336
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2021
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Promoting Shared Decision Making in Periviable Care: A randomized controlled trial of the Periviable GOALS Decision Support Tool
-
批准号:10491110
-
项目类别:
-
资助金额:$38.65万
-
财政年份:2021
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Promoting Shared Decision Making in Periviable Care: A randomized controlled trial of the Periviable GOALS Decision Support Tool
-
批准号:10693922
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2021
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Transdisciplinary Research Training to Reduce Disparities in Preterm Birth and Improve Maternal and Neonatal Outcomes
-
批准号:9921460
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2019
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Transdisciplinary Research Training to Reduce Disparities in Preterm Birth and Improve Maternal and Neonatal Outcomes
-
批准号:10400055
-
项目类别:
-
资助金额:$42.26万
-
财政年份:2019
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Transdisciplinary Research Training to Reduce Disparities in Preterm Birth and Improve Maternal and Neonatal Outcomes
-
批准号:10612870
-
项目类别:
-
资助金额:$12.12万
-
财政年份:2019
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Effect of a patient-centered decision app on TOLAC: An RCT
-
批准号:8885864
-
项目类别:
-
资助金额:$63.74万
-
财政年份:2014
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Effect of a patient-centered decision app on TOLAC: An RCT
-
批准号:9274339
-
项目类别:
-
资助金额:$63.38万
-
财政年份:2014
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Effect of a patient-centered decision app on TOLAC: An RCT
-
批准号:8760269
-
项目类别:
-
资助金额:$70.51万
-
财政年份:2014
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Expanded Prenatal Testing Options and Informed Choice
-
批准号:7933158
-
项目类别:
-
资助金额:$6.03万
-
财政年份:2009
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Development and Pilot Test of an Elective BSO Decision Support Guide
-
批准号:7707960
-
项目类别:
-
资助金额:$20.39万
-
财政年份:2009
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Expanded Prenatal Testing Options and Informed Choice
-
批准号:7226022
-
项目类别:
-
资助金额:$37.89万
-
财政年份:2006
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Expanded Prenatal Testing Options and Informed Choice
-
批准号:7585203
-
项目类别:
-
资助金额:$39.04万
-
财政年份:2006
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Expanded Prenatal Testing Options and Informed Choice
-
批准号:7032858
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2006
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Expanded Prenatal Testing Options and Informed Choice
-
批准号:7388203
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2006
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Expanded Prenatal Testing Options and Informed Choice
-
批准号:7774331
-
项目类别:
-
资助金额:$24.34万
-
财政年份:2006
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Intermediate Outcomes of Hysterectomy and Alternatives
-
批准号:6799546
-
项目类别:
-
资助金额:$55.76万
-
财政年份:2002
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Intermediate Outcomes of Hysterectomy and Alternatives
-
批准号:6615574
-
项目类别:
-
资助金额:$59.39万
-
财政年份:2002
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Intermediate Outcomes of Hysterectomy and Alternatives
-
批准号:6935808
-
项目类别:
-
资助金额:$58.2万
-
财政年份:2002
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
Intermediate Outcomes of Hysterectomy and Alternatives
-
批准号:7122968
-
项目类别:
-
资助金额:$51.23万
-
财政年份:2002
-
负责人:MIRIAM KUPPERMANN
-
依托单位:
海外基金